Kaposi’s Sarcoma
Definition: A vascular Tumor associated with
human herpes virus 8 (HHV-8).
•Manifest as multiple nodule in skin or other
organs.
•First described in 1872 by Moritz Kaposi.
•KS remained a rare disease until HIV epidemic.
•Kaposi’s sarcoma is a disease of men (15:1)
Patients seen in the past 8 years: 83 cases
Male 53, and 30 Female
Sex ratio : 2:1
Types of Kaposi’s
Four clinical types have been recognized:
1. Classical Kaposi’s Sarcoma ( 1872)
2. African Kaposi’s Sarcoma (1950)
3.Transplant related KS (1969)
4. Epidemic Kaposi’s Sarcoma (1981)
=> The histological feature is similar
Classical Kaposi’s Sarcoma
Affect mainly elderly men of Mediterranean or
Jewish origin
Lesion start usually as reddish nodule on the
lower extremities
Generally indolent disease (10 to 15 years)
About 20% die as a direct result of KS
Gastrointestinal or pulmonary involvement
Many of these patients develop second
malignancy
e.g. Lymphoma
African Kaposi’s Sarcoma
Common malignancy In Central Africa
3 – 9 % of all malignancies
Occur in young men, variable clinical course:
• Indolent to aggressive
• Sex ratio 14:1
• Involve extremities, usually generalized
It is not associated to immune deficiency
Immunosuppressive treatment
related KS
Renal transplant, first case reported 1969
The incidence is 150 to 200 times more than general
population
Some cases regress following stopping,
reducing or changing of immunosuppressant
Epidemic Kaposi’s Sarcoma
Occurs in 20% of AIDS patients
The clinical feature resembles transplant
associated KS
Widely disseminated involving the viscera
Rapidly fatal course
It arise from multiple foci
Staging classification of AIDS related
KS
Staging classification of AIDS associated KS
Good risk (0) Poor risk (1)
(all of the parameters listed) (Any of the parameters listed)
Tumor Small tumor with limited Large tumor burden:
involvement of one or more: Oral
Skin Pulmonary
Oral GI
Lymph node Other visceral invo.
Immune system (I) CD4 >200 /mm3 CD4 cells < 200/ mm3
Systemic Illness (S) No Oppor. inf History of opport. infec
No B symptoms B symptoms
Indications for treatment (Epidemic KS)
1. Pulmonary Kaposi’s Sarcoma
2. Painful nodule or ulcerating foot lesions
3. Function limiting lymph edema
4. Cosmetic
5. Social stigma
Treatment
Two modalities:
1. Local modalities
1.1 Surgery
1.2. Radiotherapy
1.3. Chemotherapy
2. Systemic modality
2.1. Chemotherapy
2.2. Antiretroviral therapy
Local modalities
1. Surgery :
1.1. Curettage
1.2. Cryotherapy
1.3. Surgical excision
In epidemic KS the place for surgical treatment is limited
2. Radiotherapy:
2.1 . Single fraction - 800 cGy
2.2. Multiple fractions:
300-400 cGy x4 = 1200 cGy – 1600 cGy
300cGy x10 = 3000cGy
=> Kaposi’s sarcoma is radiosensitive
3. Chemotherapy:
Intra-lesional injection
Systemic Therapy
I. Chemotherapy
2.1. Single agent
2.2. Combination
II. Antiretroviral
Decreased new AIDS cases with KS
Regression in the size of existing KS lesions
Improve survival
Prognostic factors for epidemic KS
1. CD4 cell count
2. Presence/ absence of systemic symptoms
3. Prior or coexisting opportunistic infection
=> Are also prognostic factors for HIV/AIDS